Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice

BACKGROUND: Several studies stablished a relationship between metabolic disturbances and Alzheimer´s disease (AD) where inflammation plays a pivotal role. However, mechanisms involved still remain unclear. In the present study, we aimed to evaluate central and peripheral effects of dexibuprofen (DXI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettcheto, Miren, Sánchez-Lopez, Elena, Cano, Amanda, Carrasco, Marina, Herrera, Katherine, Manzine, Patricia R., Espinosa-Jimenez, Triana, Busquets, Oriol, Verdaguer, Ester, Olloquequi, Jordi, Auladell, Carme, Folch, Jaume, Camins, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296685/
https://www.ncbi.nlm.nih.gov/pubmed/34294142
http://dx.doi.org/10.1186/s13578-021-00646-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296685/
https://www.ncbi.nlm.nih.gov/pubmed/34294142
http://dx.doi.org/10.1186/s13578-021-00646-w

Ejemplares similares